RUA Life Sciences (GB:RUA) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
RUA Life Sciences has strategically expanded its contract manufacturing business with the acquisition of Analytic Biosurgical Solutions SAS (Abiss), a company specializing in implantable medical devices, for €80,000. Abiss, which was not in liquidation despite its parent company’s insolvency, has a strong track record with innovative surgical implants, owns intellectual property rights, and has a growing contract manufacture business. This acquisition is set to bolster RUA’s medium-term growth targets and complements its existing customer relationships and reputation for quality in the medical device sector.
For further insights into GB:RUA stock, check out TipRanks’ Stock Analysis page.